Micaela Gal
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Clostridium difficile and Clostridium perfringens research 5
- Viral gastroenteritis research and epidemiology 3
- Antimicrobial Resistance in Staphylococcus 3
-
- Urinary Tract Infections Management 6
- Co-authors
- Christopher Butler (23 shared papers)Kerenza Hood (19 shared papers)Nick Francis (14 shared papers)Mandy Wootton (8 shared papers)John Brazier (3 shared papers)Emma Thomas‐Jones (12 shared papers)Ruth C. Massey (1 shared paper)Andrew J. Spiers (1 shared paper)
- Journals
- Trials (3 papers)British Journal of General Practice (3 papers)The Lancet (3 papers)PLoS ONE (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- United KingdomAustraliaSpain
In The Last Decade
Micaela Gal
35 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 99
- Applied Microbiology and Biotechnology 123
- Clinical Biochemistry 141
- Infectious Diseases 223
- Molecular Medicine 53
- Otorhinolaryngology 32
Countries citing papers authored by Micaela Gal
This map shows the geographic impact of Micaela Gal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micaela Gal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micaela Gal more than expected).
Fields of papers citing papers by Micaela Gal
This network shows the impact of papers produced by Micaela Gal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micaela Gal. The network helps show where Micaela Gal may publish in the future.
Co-authors
The 25 scholars most cited alongside Micaela Gal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 157 | |
| 2 | 2003 | 101 | |
| 3 | 2004 | 96 | |
| 4 | 2017 | 62 | |
| 5 | 2005 | 60 | |
| 6 | 2019 | 54 | |
| 7 | 2004 | 50 | |
| 8 | 2017 | 37 | |
| 9 | 2003 | 36 | |
| 10 | 2018 | 34 | |
| 11 | 2017 | 32 | |
| 12 | 2015 | 28 | |
| 13 | 2019 | 26 | |
| 14 | 2014 | 26 | |
| 15 | 2017 | 25 | |
| 16 | 2005 | 25 | |
| 17 | 2018 | 23 | |
| 18 | 2005 | 22 | |
| 19 | 2012 | 20 | |
| 20 | 2018 | 16 |
About Micaela Gal
Micaela Gal is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Clinical Biochemistry and Applied Microbiology and Biotechnology, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include Urinary Tract Infections Management (6 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Antibiotic Use and Resistance (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Streptococcal Infections and Treatments (4 papers), Viral gastroenteritis research and epidemiology (3 papers), Ear Surgery and Otitis Media (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (123 citations), Clinical Biochemistry (141 citations), Infectious Diseases (223 citations), Molecular Medicine (53 citations) and Otorhinolaryngology (32 citations). Micaela Gal has collaborated with scholars based in United Kingdom, Australia and Spain. Frequent co-authors include Christopher Butler, Kerenza Hood, Nick Francis, Mandy Wootton, John Brazier, Emma Thomas‐Jones, Ruth C. Massey, Andrew J. Spiers, Gail M. Preston and Paul B. Rainey. Their work appears in journals such as Trials, British Journal of General Practice, The Lancet, PLoS ONE and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.